Muralidhar Beeram Selected Research

Muralidhar Beeram Research Topics

Disease

25	Neoplasms (Cancer) 01/2021 - 10/2002
8	Fatigue 01/2019 - 06/2010
7	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2010
6	Exanthema (Rash) 01/2018 - 12/2006
5	Neutropenia 02/2017 - 01/2007
4	Nausea 03/2016 - 06/2010
4	Melanoma (Melanoma, Malignant) 01/2016 - 02/2007
3	Thrombocytopenia (Thrombopenia) 07/2014 - 06/2010
2	Stomatitis 01/2018 - 02/2017
2	Mucositis 02/2017 - 04/2012
2	Pruritus (Itching) 03/2016 - 08/2014
2	Vomiting 03/2016 - 06/2013
2	Proteinuria 07/2014 - 05/2014
2	Alopecia (Baldness) 05/2014 - 06/2013
2	Diarrhea 06/2013 - 12/2006
2	Fever (Fevers) 06/2007 - 01/2007
1	Bone Diseases (Bone Disease) 01/2021
1	Cholangiocarcinoma 01/2019
1	Dermatitis 01/2018
1	Hypokalemia 01/2018
1	Paronychia 01/2018
1	Tremor (Tremors) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 03/2016
1	Constipation 03/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Infections 10/2015
1	Gastritis 10/2015
1	Pericarditis 10/2014
1	Inflammation (Inflammations) 08/2014
1	Obesity 08/2014
1	Overweight 08/2014
1	Hand-Foot Syndrome 07/2014
1	Hypertension (High Blood Pressure) 07/2014
1	Dysphonia (Spastic Dysphonia) 05/2014
1	Febrile Neutropenia 06/2013
1	Body Weight (Weight, Body) 05/2012

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 03/2016 - 01/2007
3	Hormones (Hormone)IBA 01/2021 - 01/2016
3	Aromatase InhibitorsIBA 01/2021 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2002
3	Monoclonal AntibodiesIBA 03/2016 - 05/2014
3	Sorafenib (BAY 43-9006)FDA Link 07/2014 - 09/2005
3	Ado-Trastuzumab EmtansineIBA 12/2012 - 06/2010
2	abemaciclibIBA 01/2021 - 01/2016
2	Tamoxifen FDA LinkGeneric 01/2021 - 03/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2016
2	p38 Mitogen-Activated Protein KinasesIBA 01/2018 - 03/2016
2	vesencumabIBA 08/2014 - 05/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 02/2007
2	Bevacizumab (Avastin)FDA Link 07/2014 - 05/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 12/2006
2	Immunoconjugates (Immunoconjugate)IBA 05/2012 - 06/2010
2	Transaminases (Aminotransferases)IBA 04/2012 - 06/2010
2	Pemetrexed (MTA)FDA Link 05/2007 - 01/2007
2	Biological ProductsIBA 02/2007 - 12/2006
1	Letrozole (Femara)FDA LinkGeneric 01/2021
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	ivosidenibIBA 01/2019
1	Phosphorus (Red Phosphorus)IBA 01/2019
1	isocitric acid (isocitrate)IBA 01/2019
1	magrolimabIBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018
1	pegfilgrastim (Neulasta)FDA Link 02/2017
1	litronesibIBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 03/2016
1	Fetal Proteins (Fetoprotein)IBA 03/2016
1	ralimetinibIBA 03/2016
1	CytokinesIBA 03/2016
1	pembrolizumabIBA 10/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2015
1	7- (4- (3- ethynylphenylamino)- 7- methoxyquinazolin- 6- yloxy)- N- hydroxyheptanamideIBA 10/2014
1	CreatinineIBA 10/2014
1	ProstaglandinsIBA 08/2014
1	Estrogens (Estrogen)FDA Link 08/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014
1	Estrogen ReceptorsIBA 08/2014
1	Aromatase (CYP19)IBA 08/2014
1	EicosanoidsIBA 08/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2014
1	Dinoprostone (PGE2)FDA Link 08/2014
1	EnzymesIBA 08/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2014
1	Ethylene Glycol (Monoethylene Glycol)IBA 06/2013
1	EZN-2208IBA 06/2013
1	Trastuzumab (Herceptin)FDA Link 12/2012
1	Epidermal Growth Factor (EGF)IBA 12/2012
1	AlbuminsIBA 05/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2012
1	Mitogen-Activated Protein KinasesIBA 04/2012

Therapy/Procedure

5	Therapeutics 01/2021 - 10/2002
3	Drug Therapy (Chemotherapy) 01/2021 - 05/2008
1	Duration of Therapy 03/2016
1	Radiotherapy 03/2016
1	Premedication 08/2014